Lux Biosciences

Developer of medications to treat ophthalmic diseases

placeNew York City, New York, United States calendar_todayFounded 2006 groups11 employees language luxbio.com

Innovation

2 patent families (2 granted) — focus: Human necessities; filing pace dormant. Cited 777 times.

YearFilings
20121
20131
20141
20182

Investor mix

7 investors on record; lead investors include HBM Healthcare Investments.

Investor typeCountShare
Venture capital571%
Private equity114%
Other / undisclosed114%
Coming soon